GLS-010 Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

Guangzhou Gloria Biosciences Co., Ltd.2

Indications

Cancer2
Persistent, Recurrent, or Metastatic Cervical Cancer1
Solid Tumor1

Other2 trials

A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Phase 3

Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.